CCT
NVO

Chemung Canal Trust’s Novo Nordisk NVO Stock Holding History

Chemung Canal Trust’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,540
Closed -$307K – 118
2025
Q3 		$307K Sell
5,540
-314
-5% -$18.4K 0.06% 103
2025
Q2 		$404K Sell
5,854
-370
-6% -$25.2K 0.08% 99
2025
Q1 		$432K Sell
6,224
-4,491
-42% -$371K 0.1% 100
2024
Q4 		$922K Sell
10,715
-417
-4% -$45.1K 0.19% 81
2024
Q3 		$1.33M Sell
11,132
-705
-6% -$94K 0.27% 67
2024
Q2 		$1.69M Sell
11,837
-135
-1% -$17.9K 0.33% 63
2024
Q1 		$1.54M Sell
11,972
-364
-3% -$43.3K 0.3% 65
2023
Q4 		$1.28M Sell
12,336
-350
-3% -$34.6K 0.26% 66
2023
Q3 		$1.15M Sell
12,686
-864
-6% -$76.1K 0.26% 66
2023
Q2 		$1.1M Sell
13,550
-10,100
-43% -$825K 0.24% 70
2023
Q1 		$1.88M Sell
23,650
-260
-1% -$18.4K 0.43% 57
2022
Q4 		$1.62M Sell
23,910
-620
-3% -$36.4K 0.37% 62
2022
Q3 		$1.22M Sell
24,530
-6,284
-20% -$337K 0.3% 68
2022
Q2 		$1.72M Buy
30,814
+2,202
+8% +$122K 0.39% 62
2022
Q1 		$1.59M Sell
28,612
-876
-3% -$45K 0.31% 69
2021
Q4 		$1.65M Buy
29,488
+44
+0.1% +$2.38K 0.3% 72
2021
Q3 		$1.41M Sell
29,444
-109,828
-79% -$5.31M 0.27% 74
2021
Q2 		$5.83M Sell
139,272
-21,854
-14% -$847K 1.12% 39
2021
Q1 		$5.43M Sell
161,126
-9,504
-6% -$339K 1.09% 38
2020
Q4 		$5.96M Buy
170,630
+56,758
+50% +$1.96M 1.25% 37
2020
Q3 		$3.95M Buy
113,872
+20,892
+22% +$696K 0.94% 44
2020
Q2 		$3.04M Buy
92,980
+52,848
+132% +$1.69M 0.8% 49
2020
Q1 		$1.21M Sell
40,132
-3,350
-8% -$99.7K 0.37% 60
2019
Q4 		$1.26M Buy
43,482
+33,482
+335% +$927K 0.29% 77
2019
Q3 		$259K Hold
10,000
– – 0.06% 109
2019
Q2 		$255K Hold
10,000
– – 0.06% 104
2019
Q1 		$262K Buy
+10,000
New +$246K 0.06% 97

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Chemung Canal Trust's NVO Position: Q4 2025 in Review

Chemung Canal Trust sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 5,540 shares — an estimated $307K sold.

Chemung Canal Trust first reported a position in NVO in Q1 2019 and held it in 27 quarters. The position peaked at $5.96M in Q4 2020. 1,416 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • Chemung Canal Trust reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • Chemung Canal Trust sold 5,540 Novo Nordisk shares in Q4 2025, an estimated $307K.
  • Chemung Canal Trust first reported a position in Novo Nordisk in Q1 2019 and held it in 27 quarters.
  • Chemung Canal Trust's Novo Nordisk position peaked at $5.96M in Q4 2020.
  • 1,416 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Chemung Canal Trust's 13F filing for Q4 2025, filed 14 Jan 2026.